Cargando…

Medical loss ratio as a potential regulatory tool in the Israeli healthcare system

BACKGROUND: The growth of the private health insurance sector in Western countries, which is characterized by information deficiencies and limited competition, necessitates the implementation of effective regulatory tools. One measure which is widely used is the medical loss ratio (MLR). Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon-Tuval, Tzahit, Horev, Tuvia, Kaplan, Giora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425899/
https://www.ncbi.nlm.nih.gov/pubmed/25960867
http://dx.doi.org/10.1186/s13584-015-0009-8
_version_ 1782370540041797632
author Simon-Tuval, Tzahit
Horev, Tuvia
Kaplan, Giora
author_facet Simon-Tuval, Tzahit
Horev, Tuvia
Kaplan, Giora
author_sort Simon-Tuval, Tzahit
collection PubMed
description BACKGROUND: The growth of the private health insurance sector in Western countries, which is characterized by information deficiencies and limited competition, necessitates the implementation of effective regulatory tools. One measure which is widely used is the medical loss ratio (MLR). Our objective was to analyze how MLR is applied as a regulatory measure in the Israeli voluntary health insurance (VHI) market in order to promote the protection of beneficiaries. The study will examine MLR values and the use of this tool by regulators of VHI in Israel. METHODS: Descriptive analysis using 2005–2012 data from public reports of the Ministry of Health and the Ministry of Finance on VHI plans in three market segments: nonprofit health plans, group (collective) policies offered by commercial insurance companies and individual policies offered by commercial insurance companies. RESULTS: In 2012, 74% of the Israeli population owned VHI provided by nonprofit health plans and 43% owned VHI offered by for-profit commercial companies. At that time the MLRs of three nonprofit health plans were significantly lower than 80%, mostly in the upper layers of coverage. The MLR in the individual commercial segment was consistently low (38% in 2012). The use of MLR as a regulation tool was, and continues to be, relatively limited in all segments. CONCLUSION: The VHI in Israel covers several essential services that are not covered by the statutory benefits package as a result of budget constraints. Thus, due to the high penetration rate of VHI in Israel compared to European countries and the lower levels of MLR, in order to assure the protection of beneficiaries it may be warranted to increase the extent of regulation and adjust it to the nature of the services covered. This may include distinguishing between essential and nonessential coverages and implementation of the most suitable regulatory measures (such as an MLR threshold, limitation of services covered and adjusting the actuarial models to the beneficiaries’ behavior), rather than focusing only on assuring solvency.
format Online
Article
Text
id pubmed-4425899
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44258992015-05-10 Medical loss ratio as a potential regulatory tool in the Israeli healthcare system Simon-Tuval, Tzahit Horev, Tuvia Kaplan, Giora Isr J Health Policy Res Original Research Article BACKGROUND: The growth of the private health insurance sector in Western countries, which is characterized by information deficiencies and limited competition, necessitates the implementation of effective regulatory tools. One measure which is widely used is the medical loss ratio (MLR). Our objective was to analyze how MLR is applied as a regulatory measure in the Israeli voluntary health insurance (VHI) market in order to promote the protection of beneficiaries. The study will examine MLR values and the use of this tool by regulators of VHI in Israel. METHODS: Descriptive analysis using 2005–2012 data from public reports of the Ministry of Health and the Ministry of Finance on VHI plans in three market segments: nonprofit health plans, group (collective) policies offered by commercial insurance companies and individual policies offered by commercial insurance companies. RESULTS: In 2012, 74% of the Israeli population owned VHI provided by nonprofit health plans and 43% owned VHI offered by for-profit commercial companies. At that time the MLRs of three nonprofit health plans were significantly lower than 80%, mostly in the upper layers of coverage. The MLR in the individual commercial segment was consistently low (38% in 2012). The use of MLR as a regulation tool was, and continues to be, relatively limited in all segments. CONCLUSION: The VHI in Israel covers several essential services that are not covered by the statutory benefits package as a result of budget constraints. Thus, due to the high penetration rate of VHI in Israel compared to European countries and the lower levels of MLR, in order to assure the protection of beneficiaries it may be warranted to increase the extent of regulation and adjust it to the nature of the services covered. This may include distinguishing between essential and nonessential coverages and implementation of the most suitable regulatory measures (such as an MLR threshold, limitation of services covered and adjusting the actuarial models to the beneficiaries’ behavior), rather than focusing only on assuring solvency. BioMed Central 2015-05-01 /pmc/articles/PMC4425899/ /pubmed/25960867 http://dx.doi.org/10.1186/s13584-015-0009-8 Text en © Simon-Tuval et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Simon-Tuval, Tzahit
Horev, Tuvia
Kaplan, Giora
Medical loss ratio as a potential regulatory tool in the Israeli healthcare system
title Medical loss ratio as a potential regulatory tool in the Israeli healthcare system
title_full Medical loss ratio as a potential regulatory tool in the Israeli healthcare system
title_fullStr Medical loss ratio as a potential regulatory tool in the Israeli healthcare system
title_full_unstemmed Medical loss ratio as a potential regulatory tool in the Israeli healthcare system
title_short Medical loss ratio as a potential regulatory tool in the Israeli healthcare system
title_sort medical loss ratio as a potential regulatory tool in the israeli healthcare system
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425899/
https://www.ncbi.nlm.nih.gov/pubmed/25960867
http://dx.doi.org/10.1186/s13584-015-0009-8
work_keys_str_mv AT simontuvaltzahit medicallossratioasapotentialregulatorytoolintheisraelihealthcaresystem
AT horevtuvia medicallossratioasapotentialregulatorytoolintheisraelihealthcaresystem
AT kaplangiora medicallossratioasapotentialregulatorytoolintheisraelihealthcaresystem